Literature DB >> 35980564

Increased pulse wave velocity is related to impaired working memory and executive function in older adults with metabolic syndrome.

Jigar Gosalia1, Polly S Montgomery2, Shangming Zhang2, William A Pomilla2, Ming Wang3, Menglu Liang3, Anna Csiszar4,5,6, Zoltan Ungvari4,5,6,7, Andriy Yabluchanskiy4,5,6,7, David N Proctor1, Andrew W Gardner8.   

Abstract

Age-related vascular alterations promote the pathogenesis of vascular cognitive impairment (VCI). Cardiovascular risk factors that accelerate vascular aging exacerbate VCI. Metabolic syndrome (MetS) constitutes a cluster of critical cardiovascular risk factors (abdominal obesity, hypertension, elevated triglycerides, elevated fasting glucose, reduced HDL cholesterol), which affects nearly 37% of the adult US population. The present study was designed to test the hypotheses that MetS exacerbates cognitive impairment and that arterial stiffening moderates the association between cognitive dysfunction and MetS in older adults. MetS was defined by the NCEP ATP III guidelines. Cognitive function (digit span and trail-making tests) and brachial-ankle pulse wave velocity (baPWV; a non-invasive clinical measurement of arterial stiffness) were assessed in older adults with MetS and age- and sex-matched controls. Multiple linear regression models were applied to test for the main effects of MetS, baPWV, and their interaction on cognitive performance. Fifty-three participants with MetS (age: 68 ± 8 years) and 39 age-matched individuals without MetS (age: 66 ± 9 years) were enrolled into the study. In adjusted multivariable regression analyses of the digit span backward length score, both MetS (ß = 1.97, p = 0.048) and MetS by baPWV interaction (ß =  - 0.001, p = 0.026) were significant predictors. In participants with MetS, higher baPWV was associated with poorer performance on digit span backward length score, a test of working memory (R =  - 0.44, p = 0.0012), but there was no association in those without MetS (R = 0.035, p = 0.83). MetS was negatively associated with performance on the digit span backward length score, baPWV was negatively associated with multiple neuropsychological outcomes, and baPWV moderated the association between digit span backward length score and MetS, as individuals with both MetS and higher baPWV had the most impaired cognitive function. Our findings add to the growing body of evidence that individuals with MetS and higher baPWV may be prone to VCI.
© 2022. The Author(s), under exclusive licence to American Aging Association.

Entities:  

Keywords:  Arterial stiffness; Brain aging; Metabolic syndrome; Neuropsychological tests; Vascular cognitive impairment

Year:  2022        PMID: 35980564     DOI: 10.1007/s11357-022-00640-1

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  62 in total

Review 1.  Vascular Cognitive Impairment.

Authors:  Martin Dichgans; Didier Leys
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

2.  Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.

Authors:  P A Boyle; R S Wilson; N T Aggarwal; Y Tang; D A Bennett
Journal:  Neurology       Date:  2006-08-08       Impact factor: 9.910

3.  Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016.

Authors:  Grishma Hirode; Robert J Wong
Journal:  JAMA       Date:  2020-06-23       Impact factor: 56.272

4.  NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.

Authors:  Charles M Alexander; Pamela B Landsman; Steven M Teutsch; Steven M Haffner
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

5.  Arterial pulse wave velocity and cognition with advancing age.

Authors:  Merrill F Elias; Michael A Robbins; Marc M Budge; Walter P Abhayaratna; Gregory A Dore; Penelope K Elias
Journal:  Hypertension       Date:  2009-02-23       Impact factor: 10.190

Review 6.  Vascular cognitive impairment.

Authors:  John T O'Brien; Timo Erkinjuntti; Barry Reisberg; Gustavo Roman; Tohru Sawada; Leonardo Pantoni; John V Bowler; Clive Ballard; Charles DeCarli; Philip B Gorelick; Kenneth Rockwood; Alistair Burns; Serge Gauthier; Steven T DeKosky
Journal:  Lancet Neurol       Date:  2003-02       Impact factor: 44.182

7.  Increased risk of falling in older community-dwelling women with mild cognitive impairment.

Authors:  Teresa Y Liu-Ambrose; Maureen C Ashe; Peter Graf; B Lynn Beattie; Karim M Khan
Journal:  Phys Ther       Date:  2008-09-26

8.  The natural history of cognitive decline in Alzheimer's disease.

Authors:  Robert S Wilson; Eisuke Segawa; Patricia A Boyle; Sophia E Anagnos; Loren P Hizel; David A Bennett
Journal:  Psychol Aging       Date:  2012-09-03

9.  Mild cognitive impairment and quality of life in the oldest old: a closer look.

Authors:  Felix S Hussenoeder; Hans-Helmut König; Ines Conrad; Susanne Roehr; Angela Fuchs; Michael Pentzek; Horst Bickel; Edelgard Moesch; Siegfried Weyerer; Jochen Werle; Birgitt Wiese; Silke Mamone; Christian Brettschneider; Kathrin Heser; Luca Kleineidam; Hanna Kaduszkiewicz; Marion Eisele; Wolfgang Maier; Michael Wagner; Martin Scherer; Steffi G Riedel-Heller
Journal:  Qual Life Res       Date:  2020-01-28       Impact factor: 4.147

10.  Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis.

Authors:  Kingshuk Pal; Naaheed Mukadam; Irene Petersen; Claudia Cooper
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-09-04       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.